Nuwellis Gets U.S. Patent for Blood Filtering Machine and Methods

Dow Jones
07/16
 

By Kelly Cloonan

 

Nuwellis has received a U.S. patent for its blood filtering system design and methods.

The medical technology company said Tuesday the patent covers methods for improving the accuracy of fluid balance calculations by incorporating the density of replacement fluids and effluent.

Most continuous renal replacement therapy systems assume a default fluid density, but actual fluid densities vary. If left uncorrected, that discrepancy can lead to clinically relevant fluid balance errors, the company said.

Nuwellis's design enables systems to account for density via user input, machine measurement, or derived data for more accurate volumetric flow tracking, the company said.

 

Write to Kelly Cloonan at kelly.cloonan@wsj.com

 

(END) Dow Jones Newswires

July 15, 2025 16:28 ET (20:28 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10